Suburban Hospital is a community-based, not-for-profit hospital serving Montgomery County, Maryland and the surrounding area since 1943. Located in Bethesda, Maryland, Suburban is the designated trauma center for Montgomery County.

There are 230 beds in Suburban Hospital Cancer Program.

During the past decade, Suburban Hospital Cancer Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Suburban Hospital Cancer Program" #1 sponsor was "NCIC Clinical Trials Group" with 3 trials, followed by "Oncotherapeutics" with 2 trials sponsored, "Dana-Farber Cancer Institute" with 1 trials sponsored, "Heron Therapeutics" with 1 trials sponsored and "National Institutes of Health Clinical Center (CC)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Suburban Hospital Cancer Program" #1 collaborator was "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Grupo Espanol de Investigacion del Cancer de Mama" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "North Central Cancer Treatment Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Suburban Hospital Cancer Program" are "Breast Cancer" (5 trials), "Colorectal Cancer" (1 trials), "Multiple Myeloma and Plasma Cell Neoplasm" (1 trials), "Nausea and Vomiting" (1 trials) and "Osteoporosis" (1 trials). Many other conditions were trialed in "Suburban Hospital Cancer Program" in a lesser frequency.

Most popular intervention types in "Suburban Hospital Cancer Program" are "Drug" (8 trials), "Other" (3 trials), "Procedure" (3 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "APF530" (1 trials), "Paclitaxel" (1 trials), "Palonosetron Hydrochloride" (1 trials), "Placebo" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Suburban Hospital Cancer Program" are 5 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Suburban Hospital Cancer Program". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Suburban Hospital Cancer Program, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Suburban Hospital Cancer Program, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".